Core Viewpoint - Gushengtang (02273) is actively expanding its presence in the Singapore market through acquisitions and partnerships, with a recent announcement of acquiring 100% equity in Da Zhong Tang PTE. LTD. [1][2] Group 1: Acquisition Details - Gushengtang Singapore TCM Healthcare Technologies Holdings Private Limited has entered into a share transfer agreement to acquire 100% equity and related rights of Da Zhong Tang PTE. LTD. [1] - Upon completion of the acquisition, Da Zhong Tang will become a subsidiary of Gushengtang, and its financial performance will be consolidated into Gushengtang's financial statements. [1] Group 2: Strategic Expansion - Gushengtang is accelerating its international expansion in traditional Chinese medicine by employing a "merger + cooperation + self-built" strategy, particularly focusing on the Singapore market. [2] - A strategic partnership was established with the digital healthcare platform 1doc, resulting in a joint venture where Gushengtang holds a 70% stake and will manage operations. [2] - The acquisition of Da Zhong Tang will add 14 new outpatient clinics to Gushengtang's operations, enhancing its service network and operational synergy in Singapore. [2]
固生堂涨超4% 拟全资收购新加坡大中堂 公司持续加快中医药出海步伐